Moderna seeking vaccine approval for use in children 12 and older

By Canadian Press

Published: May 25, 2021 at 3:25 PM

Protect. Close up doctor or nurse giving vaccine to patient using the syringe injected. Works in face mask. Protection against coronavirus, COVID-19 pandemic and pneumonia. Healthcare, medicine.istock.com/master1305

The drugmaker says a study of 3,700 children in the 12to17yearold age group found its mRNA vaccine was both safe and effective.

Moderna is going to ask Canadian, American and other global regulators to authorize its COVID-19 vaccine for use in children as young as 12.

The drugmaker says a study of 3,700 children in the 12-to-17-year-old age group found its mRNA vaccine was both safe and effective.

The tweens and teens got the same size doses as adults, four weeks apart.

So far, the Pfizer-BioNTech vaccine is the only one available in Canada for children as young as 12.